$15,500 of GUARDANT HEALTH INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-P)."
You can find more data on corporate lobbying on Quiver Quantitative.
GH Insider Trading Activity
GH insiders have traded $GH stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:
- KUMUD KALIA (Chief Information Officer) has made 0 purchases and 2 sales selling 10,500 shares for an estimated $355,782.
- IAN T CLARK has made 0 purchases and 2 sales selling 8,318 shares for an estimated $244,929.
- MUSA TARIQ has made 0 purchases and 4 sales selling 2,668 shares for an estimated $95,208.
- MEGHAN V. JOYCE has made 0 purchases and 3 sales selling 3,096 shares for an estimated $94,456.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GH Hedge Fund Activity
We have seen 145 institutional investors add shares of GH stock to their portfolio, and 119 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 5,277,257 shares (-52.1%) from their portfolio in Q4 2024, for an estimated $161,220,201
- PARKWOOD LLC removed 2,800,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $85,540,000
- CADIAN CAPITAL MANAGEMENT, LP removed 1,708,909 shares (-24.7%) from their portfolio in Q4 2024, for an estimated $52,207,169
- INVESCO LTD. removed 1,511,077 shares (-52.1%) from their portfolio in Q4 2024, for an estimated $46,163,402
- UBS GROUP AG added 1,394,324 shares (+386.2%) to their portfolio in Q4 2024, for an estimated $42,596,598
- CITADEL ADVISORS LLC added 1,151,488 shares (+348.5%) to their portfolio in Q4 2024, for an estimated $35,177,958
- TWO SIGMA ADVISERS, LP added 1,138,300 shares (+96.7%) to their portfolio in Q4 2024, for an estimated $34,775,065
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GH Analyst Ratings
Wall Street analysts have issued reports on $GH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 03/05/2025
- Bernstein issued a "Outperform" rating on 01/10/2025
To track analyst ratings and price targets for GH, check out Quiver Quantitative's $GH forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
